Skip to main content
. Author manuscript; available in PMC: 2010 Mar 15.
Published in final edited form as: Clin Cancer Res. 2009 Mar 10;15(6):1954–1963. doi: 10.1158/1078-0432.CCR-08-1290

Figure 4. The MHC Class II immunodominant epitope of SPANX-B is presented in the context of HLA-DR.

Figure 4

Figure 4

Figure 4

The Pep-9 –induced activation of the CD4+ T cell lines, i.e. generated to SPANX-B protein (A), or Pep-5 (B), or Pep-9 (C) can be abrogated by the presence of anti-HLA-DR Ab. In contrast, the presence of antibodies to HLA-DQ, or HLA-DP or MHC class I (anti-HLA-A,B,C) did not affect activity of CD4+ T cells. ***P<0.001 value is for comparison with the group indicated by line. Shown, mean ± SEM of representative and reproducible results of two independent experiments performed in triplicates for each panel.